Walleye Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Walleye Capital’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-294,229	Closed	-$4.63M	–	6147
2024 Q1	$4.63M	Sell	294,229 -37,403	-11%	-$576K	0.01%	1352
2023 Q4	$5.35M	Buy	+331,632	New	+$4.23M	0.01%	1065
2022 Q4	–	Sell	-19,364	Closed	-$358K	–	3746
2022 Q3	$358K	Buy	+19,364	New	+$304K	0.01%	1697
2022 Q1	–	Sell	-115,565	Closed	-$1.13M	–	2680
2021 Q4	$1.13M	Buy	115,565 +109,674	+1,862%	+$2.06M	0.04%	514
2021 Q3	$200	Buy	+5,891	New	+$188K	0.01%	1192

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Walleye Capital's DCPH Position: Q2 2024 in Review

Walleye Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 294,229 shares — an estimated $4.63M sold.

Walleye Capital first reported a position in DCPH in Q3 2021 and held it in 5 quarters. The position peaked at $5.35M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Walleye Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 294,229 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4.63M.
Walleye Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Walleye Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.35M in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.